Info:Warfarin |
PubMed:Interaction between warfarin and Korean red ginseng in patients with cardiac valve replacement. |
PubMed:Effect of the moderate consumption of olestra in patients receiving long-term warfarin therapy. |
PubMed:Long term oral anticoagulant therapy with warfarin: experience with local patient population in kuwait. |
PubMed:Edoxaban: a focused review of its clinical pharmacology. |
PubMed:Beyond warfarin: A patient-centered approach to selecting novel oral anticoagulants for stroke prevention in atrial fibrillation. |
PubMed:Evaluation of the biointeraction of colorant flavazin with human serum albumin: insights from multiple spectroscopic studies, in silico docking and molecular dynamics simulation. |
PubMed:Drug-drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects. |
PubMed:The Role of Rivaroxaban in Atrial Fibrillation and Acute Coronary Syndromes. |
PubMed:[New treatments for stroke and thromboembolism prevention in atrial fibrillation]. |
PubMed:Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population. |
PubMed:New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusions. |
PubMed:Bioavailability and activity of natural food additive triterpenoids as influenced by protein. |
PubMed:Ensuring medication adherence with direct oral anticoagulant drugs: Lessons from adherence with vitamin K antagonists (VKAs). |
PubMed:Evaluating warfarin management by pharmacists in a community teaching hospital. |
PubMed:Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial. |
PubMed:Fondaparinux as alternative anticoagulant to warfarin or low-molecular-weight heparin for recurrent venous thrombosis. |
PubMed:Emergency department management of patients on novel oral anticoagulant agents. |
PubMed:[Efficacy and safety of apixaban compared with warfarin regarding time within the therapeutic range]. |
PubMed:Alternative to oral dicoumarin anticoagulants: Considerations in dental care. |
PubMed:New Oral Anticoagulants in Practice: Pharmacological and Practical Considerations. |
PubMed:Antithrombotic alternatives for stroke prevention in atrial fibrillation: critical differences and remaining questions. |
PubMed:The new era of anticoagulation. |
PubMed:Competitive interactions of anti-carcinogens with serum albumin: a spectroscopic study of bendamustine and dexamethasone with the aid of chemometrics. |
PubMed:Determination of bioequivalence for drugs with narrow therapeutic index: reduction of the regulatory burden. |
PubMed:Local verification and assignment of mean normal prothrombin time and International Sensitivity Index values across various instruments: recent experience and outcome from North America. |
PubMed:Alogliptin: A new dipeptidyl peptidase-4 inhibitor for the management of type 2 diabetes mellitus. |
PubMed:Cost-effectiveness analysis of intracranial stent placement versus contemporary medical management in patients with symptomatic intracranial artery stenosis. |
PubMed:Betrixaban (PRT054021): pharmacology, dose selection and clinical studies. |
PubMed:Deep vein thrombosis and novel oral anticoagulants: a clinical review. |
PubMed:Pharmacogenetics and coumarin dosing--recalibrating expectations. |
PubMed:Bleeding events following concurrent use of warfarin and oseltamivir by Medicare beneficiaries. |
PubMed:A comparison of results of the US food and drug administration's mini-sentinel program with randomized clinical trials: the case of gastrointestinal tract bleeding with dabigatran. |
PubMed:Novel oral anticoagulants for stroke prevention in the geriatric population. |
PubMed:Inadvertent exaggerated anticoagulation following use of bismuth subsalicylate in an enterally fed patient receiving warfarin therapy. |
PubMed:Cost implications of formulary decisions on oral anticoagulants in nonvalvular atrial fibrillation. |
PubMed:Adverse events in patients initiated on dabigatran etexilate therapy in a pharmacist-managed anticoagulation clinic. |
PubMed:Dabigatran etexilate for thromboembolic prophylaxis in non-valvular atrial fibrillation: the RE-LY study and substudies with commentary. |
PubMed:Practical considerations in the use of novel oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation. |
PubMed:Advantages and limitations of the new anticoagulants. |
PubMed:Genetics-based pediatric warfarin dosage regimen derived using pharmacometric bridging. |
PubMed:Drug adherence in patients taking oral anticoagulation therapy. |
PubMed:Balancing efficacy and bleeding risk in the prevention of stroke due to atrial fibrillation with newer oral anticoagulants. |
PubMed:Antithrombotic therapy for pregnant women. |
PubMed:Cranberry juice ingestion and clinical drug-drug interaction potentials; review of case studies and perspectives. |
PubMed:Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery. |
PubMed:The promise of pharmacoepidemiology in helping clinicians assess drug risk. |
PubMed:Novel oral anticoagulants: a review of new agents. |
PubMed:Patients satisfaction with warfarin and willingness to switch to dabigatran: a patient survey. |
PubMed:Apixaban in the prevention of stroke and systemic embolism in nonvalvular atrial fibrillation. |
PubMed:New alternative anticoagulants in atrial fibrillation: the move beyond warfarin. |
PubMed:Clinical strategies for selecting oral anticoagulants in patients with atrial fibrillation. |
PubMed:The changing face of oral anticoagulants. |
PubMed:Kcentra: a 4-factor prothrombin complex concentrate for reversal of warfarin anticoagulation. |
PubMed:Data mining of the public version of the FDA Adverse Event Reporting System. |
PubMed:Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation. |
PubMed:[Anticoagulation in atrial fibrillation: new therapeutic alternatives]. |
PubMed:Supratherapeutic international normalized ratio due to reduced vitamin K intake secondary to prolonged vomiting in a patient on warfarin. |
PubMed:European cardiac nurses' current practice and knowledge on anticoagulation therapy. |
PubMed:Novel oral anticoagulants for stroke prevention in atrial fibrillation: a focus on the older patient. |
PubMed:Updated guidelines on outpatient anticoagulation. |
PubMed:The safety and efficacy of apixaban : where do we stand in 2013? |
PubMed:[The change of paradigm in stroke prevention in atrial fibrillation. Challenges and emerging opportunities for the family physician]. |
PubMed:[Direct oral thrombin inhibitor, "dabigatran"]. |
PubMed:One-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events. |
PubMed:Anticoagulation for non-valvular atrial fibrillation: new anticoagulant agents. |
PubMed:[ANMCO statement on prevention of thromboembolism in atrial fibrillation and role of the new oral anticoagulants]. |
PubMed:Rivaroxaban for the treatment of acute coronary syndromes. |
PubMed:Characteristics and essences upon conjugation of imidacloprid with two model proteins. |
PubMed:Tutorial in oral antithrombotic therapy: biology and dental implications. |
PubMed:Stroke prevention in atrial fibrillation--an Asian stroke perspective. |
PubMed:Left atrial appendage closure devices. Their role in 2013. |
PubMed:Dabigatran and postmarketing reports of bleeding. |
PubMed:A new era of oral anticoagulation in atrial fibrillation: implications in clinical practice. |
PubMed:Recent advances in antithrombotic therapy for stroke prevention in patients with atrial fibrillation. |
PubMed:Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation. |
PubMed:Direct thrombin and factor Xa inhibition for stroke prevention in patients with atrial fibrillation. |
PubMed:Novel oral anticoagulants: a review of the literature and considerations in special clinical situations. |
PubMed:The discovery of dabigatran etexilate. |
PubMed:Antithrombotics for stroke prevention in non-valvular atrial fibrillation: an update. |
PubMed:Rash associated with dabigatran etexilate. |
PubMed:The pharmacology and therapeutic use of dabigatran etexilate. |
PubMed:Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: dawn of a new era. |
PubMed:Medication dyes as a source of drug allergy. |
PubMed:Review of recently approved alternatives to anticoagulation with warfarin for emergency clinicians. |
PubMed:New oral anticoagulants in elderly patients with atrial fibrillation. |
PubMed:[Dabigatran as an alternative to warfarin for the prevention of thromboembolism in atrial fibrillation]. |
PubMed:Deficiencies of the FDA in evaluating generic formulations: addressing narrow therapeutic index drugs. |
PubMed:Anticoagulant prevention in patients with atrial fibrillation: alternatives to vitamin K antagonists. |
PubMed:Role of new drugs for management of atrial fibrillation. |
PubMed:Management of atrial fibrillation: direct factor IIa and Xa inhibitors or "warfarin shotgun"? |
PubMed:Transitions of care in patients receiving oral anticoagulants: general principles, procedures, and impact of new oral anticoagulants. |
PubMed:Dabigatran: a cause of hematologic emergency. |
PubMed:Comparing new anticoagulants. |
PubMed:An update on antithrombotic therapy in atrial fibrillation: the role of newer and emergent drugs. |
PubMed:[Dabigatran etexilate in clinical practice for prevention of thromboembolic events in patients with atrial fibrillation]. |
PubMed:Dabigatran compared with warfarin for stroke prevention with atrial fibrillation: experience in Hong Kong. |
PubMed:Underreporting of hemorrhagic and thrombotic complications of pharmaceuticals to the U.S. Food and Drug Administration: empirical findings for warfarin, clopidogrel, ticlopidine, and thalidomide from the Southern Network on Adverse Reactions (SONAR). |
PubMed:The new oral anticoagulants: a challenge for hospital formularies. |
PubMed:Target-specific oral anticoagulants for stroke prevention in patients with atrial fibrillation: real-world considerations. |
PubMed:Stroke prevention in atrial fibrillation: impact of novel oral anticoagulants. |
PubMed:New oral anticoagulants: a review of the literature with particular emphasis on patients with impaired renal function. |
PubMed:Comparative effectiveness of warfarin and new oral anticoagulants for the management of atrial fibrillation and venous thromboembolism: a systematic review. |
PubMed:Management of oral anticoagulation in patients undergoing minor dental procedures. |
PubMed:Systematic review and adjusted indirect comparison meta-analysis of oral anticoagulants in atrial fibrillation. |
PubMed:Enantioselective binding interaction of the metolachlor pesticide enatiomers with bovine serum albumin--a spectroscopic analysis study. |
PubMed:Botanical-drug interactions: a scientific perspective. |
PubMed:Aspirin- and clopidogrel-associated bleeding complications: data mining of the public version of the FDA adverse event reporting system, AERS. |
PubMed:Safety and efficacy of apixaban in the treatment of atrial fibrillation. |
PubMed:Emerging anticoagulant therapies for atrial fibrillation: new options, new challenges. |
PubMed:An evidence-based review of apixaban and its potential in the prevention of stroke in patients with atrial fibrillation. |
PubMed:Complications of anticoagulation. |
PubMed:Emergency management of bleeding associated with old and new oral anticoagulants. |
PubMed:Antithrombotic therapy for secondary stroke prevention. |
PubMed:Fatal gastrointestinal hemorrhage after a single dose of dabigatran. |
PubMed:Hemopericardium and cardiac tamponade associated with dabigatran use. |
PubMed:[Apixaban]. |
PubMed:Bioevaluation of human serum albumin-hesperidin bioconjugate: insight into protein vector function and conformation. |
PubMed:Dabigatran for the prevention of thromboembolic complications in the elderly: a RE-LY-able alternative to warfarin? |
PubMed:Rapid LC-MS/MS determination and pharmacokinetic application of linarin in rat plasma. |
PubMed:New oral anticoagulants: will they replace warfarin? |
PubMed:Jonathan E. Rhoads lecture 2012: improving patient care with practice-based research. |
PubMed:Multispectroscopic and molecular modeling approach to investigate the interaction of flavokawain B with human serum albumin. |
PubMed:Development and validation of LC-MS/MS method for the estimation of β-hydroxy-β-methylbutyrate in rat plasma and its application to pharmacokinetic studies. |
PubMed:A guidance pathway for the selection of novel anticoagulants in the treatment of atrial fibrillation. |
PubMed:Clinical pharmacokinetics and pharmacodynamics of linagliptin. |
PubMed:Evaluation of food-drug interaction of guava leaf tea. |
PubMed:Oral IIa and Xa inhibitors for prevention of stroke in atrial fibrillation: clinical studies and regulatory considerations. |
PubMed:[Old and new oral anticoagulants. Pharmacological perspective]. |
PubMed:[Possible interaction between pomegranate juice and warfarin]. |
PubMed:New anticoagulants in ischemic heart disease. |
PubMed:Vitamin K nutrition, metabolism, and requirements: current concepts and future research. |
PubMed:Implementing the new oral anticoagulants into the hospital formulary. |
PubMed:The Efficacy of Rivaroxaban in Patients With Atrial Fibrillation. |
PubMed:Dabigatran: a new chapter in anticoagulation. |
PubMed:Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. |
PubMed:Use of direct thrombin inhibitor for treatment of cerebral venous thrombosis. |
PubMed:Novel drugs for oral anticoagulation pharmacotherapy. |
PubMed:Biophysical influence of isocarbophos on bovine serum albumin: spectroscopic probing. |
PubMed:Dabigatran etexilate: an oral direct thrombin inhibitor for the management of thromboembolic disorders. |
PubMed:Dabigatran or warfarin for the prevention of stroke in atrial fibrillation? A closer look at the RE-LY trial. |
PubMed:Successful management of anticoagulation therapy during international travel. |
PubMed:Dabigatran: comparison to warfarin, pathway to approval, and practical guidelines for use. |
PubMed:Newer anticoagulants in cardiovascular disease: a systematic review of the literature. |
PubMed:Identification of cytochrome P450 2D6 and 2C9 substrates and inhibitors by QSAR analysis. |
PubMed:Epidural hematoma and intraoperative hemorrhage in a spine trauma patient on Pradaxa (dabigatran). |
PubMed:Effects of subacute oral warfarin administration on peripheral blood granulocytes in rats. |
PubMed:Clinical pharmacokinetics and pharmacodynamics of vildagliptin. |
PubMed:I recently heard that there are alternative medications to the blood thinner warfarin. What are they, and how are they different? |
PubMed:Apixaban for the prevention of stroke in atrial fibrillation. |
PubMed:Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature. |
PubMed:New frontiers for stroke prevention in atrial fibrillation. |
PubMed:Heparin-induced thrombocytopenia. |
PubMed:Cranberry and warfarin interaction: a case report and review of the literature. |
PubMed:Newer anticoagulants for non-valvular atrial fibrillation. |
PubMed:Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies. |
PubMed:Spontaneous splenic hemorrhage after initiation of dabigatran (Pradaxa) for atrial fibrillation. |
PubMed:Rivaroxaban (Xarelto) for acute coronary syndrome. |
PubMed:Dabigatran etexilate: what do hospitalists need to know? |
PubMed:Role of pharmacogenomics in the management of traditional and novel oral anticoagulants. |
PubMed:FDA advisory decision highlights some problems inherent in pragmatic trials. |
PubMed:Single-walled carbon nanotubes based quenching of free FAM-aptamer for selective determination of ochratoxin A. |
PubMed:Dietary interactions and INR variability: retrospective evaluation of patients couples on oral anticoagulant therapy. |
PubMed:Competitive binding of small molecules with biopolymers: a fluorescence spectroscopy and chemometrics study of the interaction of aspirin and ibuprofen with BSA. |
PubMed:What risk do consumers face when seeking medical advice from health food stores? |
PubMed:Multivariate analysis of the relation between diet and warfarin dose. |
PubMed:Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant. |
PubMed:New anticoagulants for the prevention of stroke in atrial fibrillation. |
PubMed:Hospital-based clinical implications of the novel oral anticoagulant, dabigatran etexilate, in daily practice. |
PubMed:Warfarin resistance and caffeine containing beverages. |
PubMed:Mechanism and conformational studies of farrerol binding to bovine serum albumin by spectroscopic methods. |
PubMed:Anticoagulant management in the cardiovascular setting. |
PubMed:Recurrent venous thrombosis despite 'optimal anticoagulation therapy' for antiphospholipid syndrome--could new oral anticoagulants solve the problem? |
PubMed:Buyer beware? Does the information provided with herbal products available over the counter enable safe use? |
PubMed:Old versus new oral anticoagulants: focus on pharmacology. |
PubMed:Update on anti-coagulation in atrial fibrillation. |
PubMed:Recent progress in anticoagulant therapy: oral direct inhibitors of thrombin and factor Xa. |
PubMed:Role of emerging antithrombotic therapy in the prevention of cardioembolic complications in patients with atrial fibrillation. |
PubMed:Dabigatran in atrial fibrillation: pharmacology and clinical trials. |
PubMed:The quality of information on websites selling St. John's wort. |
PubMed:New oral anticoagulants for venous thromboembolism prophylaxis in orthopaedic surgery. |
PubMed:What is the state of the art in orthopaedic thromboprophylaxis in lower extremity reconstruction? |
PubMed:Spotlight on dabigatran etexilate in the prevention of stroke and systemic embolism in patients with atrial fibrillation. |
PubMed:Dabigatran etexilate: a novel oral thrombin inhibitor for thromboembolic disease. |
PubMed:New oral anticoagulants and outpatient prophylaxis of venous thromboembolism. |
PubMed:New options for stroke prevention in atrial fibrillation. |
PubMed:Anticoagulant options--why the FDA approved a higher but not a lower dose of dabigatran. |
PubMed:Incidental atrial fibrillation and its management. |
PubMed:Dabigatran etexilate: the first oral anticoagulant available in the United States since warfarin. |
PubMed:New drug offers warfarin alternative for atrial fibrillation. An immediate switch is right for some people, but not necessary for all. |
PubMed:Evaluation of warfarin drug interaction listings in US product information for warfarin and interacting drugs. |
PubMed:Thromboembolism. |
PubMed:Warfarin-cranberry juice interaction. |
PubMed:Drug and dietary interactions of warfarin and novel oral anticoagulants: an update. |
PubMed:New oral anticoagulants. |
PubMed:Case report: Cranberry juice and warfarin. |
PubMed:Genetic warfarin dosing: tables versus algorithms. |
PubMed:Dabigatran etexilate: a review of its use in the prevention of stroke and systemic embolism in patients with atrial fibrillation. |
PubMed:Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism. |
PubMed:New alternative to warfarin may help reduce stroke risk in patients with AF. |
PubMed:Eicosapentaenoic acid reduces warfarin-induced arterial calcification in rats. |
PubMed:Role of cytochrome P450 genotype in the steps toward personalized drug therapy. |
PubMed:Dabigatran emerges as safe and effective warfarin alternative. The recently approved drug is more expensive, but appears to be more predictable. |
PubMed:A potential interaction between warfarin and atovaquone. |
PubMed:The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism. |
PubMed:Spectrophotometric study of the interaction between chlorotetracycline and bovine serum albumin using Eosin Y as site marker with the aid of chemometrics. |
PubMed:Learning from product labels and label changes: how to build pharmacogenomics into drug-development programs. |
PubMed:Is it OK to drink cranberry juice if I take Coumadin? |
PubMed:A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation. |
PubMed:Effect of intrinsic and extrinsic factors on the clinical pharmacokinetics and pharmacodynamics of prasugrel. |
PubMed:Evaluation of the effect of lime fruit juice on the anticoagulant effect of warfarin. |
PubMed:My wife and I both take warfarin because we have atrial fibrillation. We've been told to stay away from green vegetables, because they are high in vitamin K. Is there a guideline for a "safe" amount to eat? |
PubMed:Personalized approaches to clopidogrel therapy: are we there yet? |
PubMed:Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48). |
PubMed:[Fifty years of clinical use of warfarin]. |
PubMed:Stroke in atrial fibrillation--hope on the horizon? |
PubMed:New oral antithrombotic agents for the prevention of deep venous thrombosis and pulmonary embolism in orthopedic surgery. |
PubMed:Warfarin genotyping using three different platforms. |
PubMed:Cutting through the statistical fog: understanding and evaluating non-inferiority trials. |
PubMed:Dabigatran: an oral novel potent reversible nonpeptide inhibitor of thrombin. |
PubMed:Relationship between dietary vitamin K intake and the stability of anticoagulation effect in patients taking long-term warfarin. |
PubMed:Effect of high-dose cranberry juice on the pharmacodynamics of warfarin in patients. |
PubMed:Sprouting a warfarin interaction. |
PubMed:Alternatives to warfarin--the next generation of anticoagulants. |
PubMed:Oral direct factor Xa inhibitors, with special emphasis on rivaroxaban. |
PubMed:Drug and dietary interactions of the new and emerging oral anticoagulants. |
PubMed:Pharmacogenetics testing: implications for cardiovascular therapeutics with clopidogrel and warfarin. |
PubMed:Analysis of the interactions of mixtures of two beta-agonists steroids with bovine serum albumin: a fluorescence spectroscopy and chemometrics investigation. |
PubMed:Discharge teaching about warfarin: patient retention of knowledge. |
PubMed:Achievement of therapeutic international normalized ratio following adjustment of tube feeds. |
PubMed:Important drug-nutrient interactions. |
PubMed:Warfarin knowledge in patients with atrial fibrillation: implications for safety, efficacy, and education strategies. |
PubMed:Warfarin bioavailability with feeding tubes and enteral formula. |
PubMed:Dabigatran etexilate, a new oral direct thrombin inhibitor, for stroke prevention in patients with atrial fibrillation. |
PubMed:[Possible interaction between probiotics and warfarin]. |
PubMed:Dietary vitamin K guidance: an effective strategy for stable control of oral anticoagulation? |
PubMed:Pharmacogenomics: bridging the gap between science and practice. |
PubMed:New approaches to atrial fibrillation management: treat the patient, not the ECG. |
PubMed:Venous thromboembolism: a clinical review. |
PubMed:[Marked PT-INR prolongation associated with appetite loss due to urinary tract infection in a late elderly case with chronic atrial fibrillation]. |
PubMed:Potential interaction between MonaVie Active and Warfarin. |
PubMed:Non ST-elevation acute coronary syndrome. |
PubMed:Probable warfarin interaction with menthol cough drops. |
PubMed:Possible interaction between pomegranate juice and warfarin. |
PubMed:Vitamin K in parenteral nutrition. |
PubMed:Interactions between quercetin and warfarin for albumin binding: A new eye on food/drug interference. |
PubMed:Goji (Lycium barbarum and L. chinense): Phytochemistry, pharmacology and safety in the perspective of traditional uses and recent popularity. |
PubMed:Comment: fatal intracranial bleed potentially due to a warfarin and influenza vaccine interaction. |
PubMed:Anticoagulant rodenticides in three owl species from Western Canada, 1988-2003. |
PubMed:Patient time requirements for anticoagulation therapy with warfarin. |
PubMed:The first evaluation of a novel vitamin K antagonist, tecarfarin (ATI-5923), in patients with atrial fibrillation. |
PubMed:Should we be applying warfarin pharmacogenetics to clinical practice? No, not now. |
PubMed:Potential interaction between pomegranate juice and warfarin. |
PubMed:Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium. |
PubMed:Potential clinical and economic outcomes of CYP2C9 and VKORC1 genotype-guided dosing in patients starting warfarin therapy. |
PubMed:The absence of an interaction between warfarin and cranberry juice: a randomized, double-blind trial. |
PubMed:Oral anticoagulation with factor Xa and thrombin inhibitors: on the threshold of change. |
PubMed:Comparison of performance of three commercial platforms for warfarin sensitivity genotyping. |
PubMed:Acute coronary syndrome (unstable angina and non-ST elevation MI). |
PubMed:Thromboembolism. |
PubMed:Chiral toxicology: it's the same thing...only different. |
PubMed:Erythrocyte folate and 5-methyltetrahydrofolate levels decline during 6 months of oral anticoagulation with warfarin. |
PubMed:Will a once-weekly anticoagulant for the treatment and secondary prevention of thromboembolism improve adherence? |
PubMed:Simultaneous determination of nonnutritive sweeteners in foods by HPLC/ESI-MS. |
PubMed:Cardiology patient pages. A patient's guide to taking coumadin/warfarin. |
PubMed:Equine cytochrome P450 2C92: cDNA cloning, expression and initial characterization. |
PubMed:Novel oral anticoagulants. |
PubMed:A regulatory science perspective on warfarin therapy: a pharmacogenetic opportunity. |
PubMed:Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation. |
PubMed:Interaction between warfarin and black tea. |
PubMed:[Nonoclusive thrombosis of mechanical mitral valve prosthesis caused by inadequate treatment of anticoagulant therapy resistance]. |
PubMed:[Warfarin resistance and related pharmacogenetic information]. |
PubMed:Pharmacogenetic testing for warfarin sensitivity. |
PubMed:Overview of pharmacogenetics in anticoagulation therapy. |
PubMed:Fatal haemopericardium and gastrointestinal haemorrhage due to possible interaction of cranberry juice with warfarin. |
PubMed:Medication administration through enteral feeding tubes. |
PubMed:Elevated International Normalized Ratio after concurrent ingestion of cranberry sauce and warfarin. |
PubMed:Determination of ochratoxin a with a DNA aptamer. |
PubMed:Interaction between capecitabine and gemcitabine with warfarin in a patient with pancreatic cancer. |
PubMed:Role of ambrisentan in the management of pulmonary hypertension. |
PubMed:Dabigatran etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases. |
PubMed:Warfarin resistance. |
PubMed:Spectrometric and voltammetric studies of the interaction between quercetin and bovine serum albumin using warfarin as site marker with the aid of chemometrics. |
PubMed:The critical path of warfarin dosing: finding an optimal dosing strategy using pharmacogenetics. |
PubMed:Clinically relevant safety issues associated with St. John's wort product labels. |
PubMed:[Factors influencing activity of oral anticoagulants. Interactions with drugs and food]. |
PubMed:Proton pump inhibitors may increase the risk of delayed bleeding complications after open heart surgery if used concomitantly with warfarin. |
PubMed:Patient knowledge on oral anticoagulants: results of a questionnaire survey in Germany and comparison with the literature. |
PubMed:Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged? |
PubMed:Pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 polymorphisms: are we there yet? |
PubMed:Advancement in antithrombotics for stroke prevention in atrial fibrillation. |
PubMed:Survival of heparins, oral anticoagulants, and aspirin after the year 2010. |
PubMed:Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database. |
PubMed:Potential interaction between warfarin and high dietary protein intake. |
PubMed:Practical aspects of treatment with drotrecogin alfa (activated). |
PubMed:Vitamin K-independent warfarin resistance after concurrent administration of warfarin and continuous enteral nutrition. |
PubMed:Warfarin overdose due to the possible effects of Lycium barbarum L. |
PubMed:Cranberry juice and warfarin: okay together? |
PubMed:Recent developments in antithrombotic therapy: will sodium warfarin be a drug of the past? |
PubMed:Potential interaction of Ginkgo biloba leaf with antiplatelet or anticoagulant drugs: what is the evidence? |
PubMed:The FDA announces new drug labeling for pharmacogenetic testing: is personalized medicine becoming a reality? |
PubMed:Factors influencing warfarin dose requirements in African-Americans. |
PubMed:Vitamin K: what are the current dietary recommendations for patients taking coumadin? |
PubMed:Anticoagulant effect of sodium dehydroacetate (DHA-S) in rats. |
PubMed:Interaction between warfarin and cranberry juice. |
PubMed:Garlic (Allium sativum L.): adverse effects and drug interactions in humans. |
PubMed:Pharmacogenomics and warfarin therapy. |
PubMed:The new anticoagulants. |
PubMed:Dietary supplements, herbs and oral anticoagulants: the nature of the evidence. |
PubMed:Outpatient-based primary and secondary thromboprophylaxis with low-molecular-weight heparin. |
PubMed:FDA encourages genetics-aided warfarin dosing. |
PubMed:Changing times: DNA resequencing and the "nearly normal autopsy". |
PubMed:[Advice for patients taking oral anticoagulants (coumadin or Previscan)]. |
PubMed:Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. |
PubMed:Varenicline: the newest agent for smoking cessation. |
PubMed:Comparison of LionHeart LVAD-implanted calves based on renal infarctions. |
PubMed:Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam--probes of CYP2C9, CYP1A2, and CYP3A4. |
PubMed:Rivaroxaban. |
PubMed:Evaluation and management of atrial fibrillation. |
PubMed:Not only green tea but also green leafy vegetables inhibit warfarin. |
PubMed:Safety considerations with omega-3 fatty acid therapy. |
PubMed:Relationship between diet and anticoagulant response to warfarin: a factor analysis. |
PubMed:Interaction potential between cranberry juice and warfarin. |
PubMed:Multiresidue analysis of seven anticoagulant rodenticides by high-performance liquid chromatography/electrospray/mass spectrometry. |
PubMed:New antithrombotic agents. |
PubMed:Oral varenicline for smoking cessation. |
PubMed:Dietary vitamin K intake and anticoagulation in elderly patients. |
PubMed:Cranberry does not affect prothrombin time in male subjects on warfarin. |
PubMed:Warfarin interaction with herbal drugs and food. |
PubMed:Potential applicability and utilization of left atrial appendage occlusion devices in patients with atrial fibrillation. |
PubMed:Cranberry and urinary tract infections: slightly fewer episodes in young women, but watch out for interactions. |
PubMed:Interaction between warfarin and cranberry juice. |
PubMed:Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices. |
PubMed:Anticoagulation and inhibition of nitric oxide synthase influence hepatic hypoxia after monocrotaline exposure. |
PubMed:Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding. |
PubMed:The challenges of new drugs benefits and risks analysis: lessons from the ximelagatran FDA Cardiovascular Advisory Committee. |
PubMed:Warfarin resistance: interaction between warfarin and Eruca sativa L. |
PubMed:[Determination of vitamin K in aojiru (green juice) products by HPLC]. |
PubMed:Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. |
PubMed:Factors influencing patient knowledge of warfarin therapy after mechanical heart valve replacement. |
PubMed:Treatment of cancer-associated thrombosis: distinguishing among antithrombotic agents. |
PubMed:[Pharmacogenetics of warfarin]. |
PubMed:Dietary supplement and selected food interactions with warfarin. |
PubMed:[Interaction between Waran and cranberry juice]. |
PubMed:Warfarin and its interactions with foods, herbs and other dietary supplements. |
PubMed:Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans. |
PubMed:Development of a cell culture/ELISA assay to detect anticoagulant rodenticides and its application to analysis of rodenticide treated grain. |
PubMed:Treatment of heparin-induced thrombocytopenia: is there a role for bivalirudin? |
PubMed:A spectroscopic study of the interaction of isoflavones with human serum albumin. |
PubMed:Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: in vitro and clinical studies. |
PubMed:Trials and tribulations of non-inferiority: the ximelagatran experience. |
PubMed:Considerations and challenges with existing treatments for thrombosis in cancer patients. |
PubMed:Quality assessment of internet pharmaceutical products using traditional and non-traditional analytical techniques. |
PubMed:Pharmacokinetics of telithromycin: application to dosing in the treatment of community-acquired respiratory tract infections. |
PubMed:Atrial fibrillation and stroke: four treatment controversies. |
PubMed:An adverse interaction between warfarin and fluoropyrimidines revisited. |
PubMed:Possible interaction between warfarin and cranberry juice. |
PubMed:Low potential for interactions between melagatran/ximelagatran and other drugs, food, or alcohol. |
PubMed:Evolving management strategies for heparin-induced thrombocytopenia. |
PubMed:Anticoagulation: new challenges, old drugs. |
PubMed:The approach to massive pulmonary embolism. |
PubMed:Pharmacology and pharmacogenetics of warfarin and other coumarins when used with supplements. |
PubMed:Clinical pharmacokinetics of losartan. |
PubMed:Uncertain times for oral anticoagulation therapy. |
PubMed:Comment: Decreased warfarin effect after initiation of high-protein, low-carbohydrate diets. |
PubMed:Systematic overview of warfarin and its drug and food interactions. |
PubMed:Efficacy and safety of rosuvastatin in treatment of dyslipidemia. |
PubMed:A better way to prevent blood clots? A drug derived from cobra venom offers an alternative to warfarin, although liver problems temper its benefits. |
PubMed:Efficacy and tolerability of the switch from a branded to a generic warfarin sodium product: an observer-blinded, randomized, crossover study. |
PubMed:Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. |
PubMed:A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer. |
PubMed:Influence of CYP2C9 polymorphisms, demographic factors and concomitant drug therapy on warfarin metabolism and maintenance dose. |
PubMed:Preventing stroke in atrial fibrillation: the SPORTIF programme. |
PubMed:Capecitabine: a review. |
PubMed:Decreased warfarin effect after initiation of high-protein, low-carbohydrate diets. |
PubMed:Oral anticoagulation: challenges in the case-management setting. |
PubMed:What's the scoop with grapefruit? |
PubMed:Interaction of warfarin with drugs, natural substances, and foods. |
PubMed:Generic warfarin: implications for clinical practice and perceptions of anticoagulation providers. |
PubMed:Interaction between Gemcitabine and Warfarin Causing Gastrointestinal Bleeding in a Patient with Pancreatic Cancer. |
PubMed:The role of oral direct thrombin inhibitors in atrial fibrillation. |
PubMed:Ximelagatran: pharmacology, pharmacokinetics, and pharmacodynamics. |
PubMed:New possibilities in anticoagulant management of atrial fibrillation. |
PubMed:Changing the guard in long-term anticoagulation: clinical and economic implications. |
PubMed:The potential for changing prescribing patterns from warfarin to oral direct thrombin inhibitors: clinical scenarios. |
PubMed:Treatment of venous thromboembolism and long-term prevention of recurrence: present treatment options and ximelagatran. |
PubMed:Clinical pharmacology of bosentan, a dual endothelin receptor antagonist. |
PubMed:[New perspectives for anticoagulation in non-rheumatic atrial fibrillation: oral antithrombins]. |
PubMed:Observations on possible effects of daily vitamin K replacement, especially upon warfarin therapy. |
PubMed:Ximelagatran in prevention of cardiovascular events. |
PubMed:New blood thinner offers first potential alternative in 50 years: ximelagatran. |
PubMed:Potential interaction between soy milk and warfarin. |
PubMed:Ximelagatran: an oral direct thrombin inhibitor. |
PubMed:Consistent vitamin K helps warfarin do its job. Food can throw off warfarin's ability to prevent blood clots. Keeping your vitamin K intake relatively constant can help you avoid problems with this medication. |
PubMed:Clinical pharmacokinetics of levetiracetam. |
PubMed:D-003 and warfarin interaction on the bleeding time and venous thrombosis experimentally induced in rats. |
PubMed:[Biological effects of vitamin K and concentration of vitamin K in Norwegian food]. |
PubMed:The scoop on green tea. |
PubMed:Vitamin K and oral anticoagulation: thought for food. |
PubMed:Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. |
PubMed:Clinical pharmacokinetics of thalidomide. |
PubMed:Of blood, bones, and broccoli: warfarin-vitamin K interactions. |
PubMed:Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs). |
PubMed:Warfarin and cranberry juice: an interaction? |
PubMed:Racial and ethnic differences in warfarin response. |
PubMed:Will direct thrombin inhibitors replace warfarin for preventing embolic events in atrial fibrillation? |
PubMed:Possible interaction between warfarin and cranberry juice. |
PubMed:Hyperhomocysteinemia and B-vitamin status after discontinuation of oral anticoagulation therapy in patients with a history of venous thromboembolism. |
PubMed:Vitamin K content of nuts and fruits in the US diet. |
PubMed:Overview of heparin-induced thrombocytopenia. |
PubMed:Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial. |
PubMed:Oral direct thrombin inhibitors in clinical development. |
PubMed:[Vitamin K in food and the effect of warfarin]. |
PubMed:The pharmacodynamics and pharmacokinetics of the oral direct thrombin inhibitor ximelagatran and its active metabolite melagatran: a mini-review. |
PubMed:Current anticoagulant therapy--unmet clinical needs. |
PubMed:Mixing medicines, herbs, food, and surgery. |
PubMed:The coagulation system contributes to synergistic liver injury from exposure to monocrotaline and bacterial lipopolysaccharide. |
PubMed:New Food and Drug Administration requirements for inclusion of vitamin K in adult parenteral multivitamins. |
PubMed:Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. SPORTIF II: a dose-guiding, tolerability, and safety study. |
PubMed:Lopinavir/ritonavir: a review of its use in the management of HIV infection. |
PubMed:Pharmacokinetics of selective estrogen receptor modulators. |
PubMed:Anticoagulation of pregnant women with mechanical heart valves. |
PubMed:Venous thromboembolism prevention with LMWHs in medical and orthopedic surgery patients. |
PubMed:Genetic and environmental risk factors for oral anticoagulant overdose. |
PubMed:Literacy, readability and cultural barriers: critical factors to consider when educating older African Americans about anticoagulation therapy. |
PubMed:[Oral anticoagulant treatment: practical aspects and significance of anticoagulant clinics]. |
PubMed:Effect of soy milk on warfarin efficacy. |
PubMed:Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions. |
PubMed:Interactions of warfarin. |
PubMed:Clinical pharmacokinetics of tegaserod, a serotonin 5-HT(4) receptor partial agonist with promotile activity. |
PubMed:Enhancement of allyl alcohol hepatotoxicity by endotoxin requires extrahepatic factors. |
PubMed:Melatonin for the prevention and treatment of jet lag. |
PubMed:Optimizing prophylaxis of venous thromboembolism. |
PubMed:Interaction between warfarin and mango fruit. |
PubMed:Is low-intensity anticoagulant therapy possible with an open pivot valve?: analysis of its development. |
PubMed:Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update. |
PubMed:Use of alternative pharmacotherapy in management of cardiovascular diseases. |
PubMed:Pharmacokinetic profile of zafirlukast. |
PubMed:FDA adverse event reports on statin-associated rhabdomyolysis. |
PubMed:Adverse events and deaths associated with laboratory errors at a hospital--Pennsylvania, 2001. |
PubMed:Seaweed, vitamin K, and warfarin. |
PubMed:Use of recombinant hirudin in heparin-induced thrombocytopenia and thrombosis (HITT) and renal failure--a case report. |
PubMed:FDA warns Merck over its promotion of rofecoxib. |
PubMed:Warfarin resistance and enteral feedings: 2 case reports and a supporting in vitro study. |
PubMed:[The safety of herbal medicines in the psychiatric practice]. |
PubMed:Drug interactions with irbesartan. |
PubMed:Uncertainty factors for chemical risk assessment. human variability in the pharmacokinetics of CYP1A2 probe substrates. |
PubMed:Practitioner report involving intravenous use of vitamin K1 prompts label review and revision. |
PubMed:Melatonin for preventing and treating jet lag. |
PubMed:Clinical pharmacokinetics of capecitabine. |
PubMed:Profile of moxifloxacin drug interactions. |
PubMed:Subtherapeutic INR values associated with a switch to generic warfarin. |
PubMed:Generic substitution: issues for problematic drugs. |
PubMed:Development of a self-assessment instrument to determine daily intake and variability of dietary vitamin K. |
PubMed:Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. |
PubMed:Tests of potential functional barriers for laminated multilayer food packages. Part II: Medium molecular weight permeants. |
PubMed:Herbs and the brain: friend or foe? The effects of ginkgo and garlic on warfarin use. |
PubMed:The interaction between vitamin K nutriture and warfarin administration in patients with bacterial overgrowth due to atrophic gastritis. |
PubMed:Dose selection and dosing interval determination for LTRA use in asthma. |
PubMed:Assessment of healthcare professionals' knowledge about warfarin-vitamin K drug-nutrient interactions. |
PubMed:Who needs individual bioequivalence studies for narrow therapeutic index drugs? A case for warfarin. |
PubMed:Warfarin and celecoxib interaction. |
PubMed:[Oral anticoagulants and medicinal plants. An emerging interaction]. |
PubMed:Response to warfarin and other oral anticoagulants: effects of disease states. |
PubMed:Management of deep venous thrombosis and pulmonary embolism. |
PubMed:Workshop: Patient Self-Management: Update of Ongoing Studies in Sweden. |
PubMed:Characteristics of rat platelets and relative contributions of platelets and blood coagulation to haemostasis. |
PubMed:Outpatient management of patients on warfarin. |
PubMed:Ciprofloxacin-warfarin coagulopathy: a case series. |
PubMed:Cyclodextrin-based optosensor for the determination of warfarin in waters. |
PubMed:Candidates for thrombolytic treatment in acute ischaemic stroke--where are our patients in Hong Kong? |
PubMed:Selective estrogen receptor modulators: a new category of compounds to extend postmenopausal women's health. |
PubMed:Vitamin K: a practical guide to the dietary management of patients on warfarin. |
PubMed:Optimizing anticoagulant therapy in the management of pulmonary embolism. |
PubMed:Assessment of the quality and quantity of drug-drug interaction studies in recent NDA submissions: study design and data analysis issues. |
PubMed:Vitamin K-supplemented snacks containing olestra: implication for patients taking warfarin. |
PubMed:Clinical pharmacokinetics of troglitazone. |
PubMed:Hypersensitivity myocarditis associated with ephedra use. |
PubMed:Medtronic Freestyle aortic root bioprosthesis: Implant techniques. |
PubMed:Clinical aspects of the use of clopidogrel, a new antiplatelet agent. |
PubMed:Grapefruit juice might still be factor in warfarin response. |
PubMed:Management of narrow therapeutic index drugs. |
PubMed:Deep venous thrombosis: early discharge strategies and outpatient management. |
PubMed:Isoniazid drug and food interactions. |
PubMed:Herbal remedies: adverse effects and drug interactions. |
PubMed:Successful percutaneous balloon mitral valvuloplasty in a patient with left atrial thrombus--a case report. |
PubMed:Protein-calorie malnutrition does not predict subtle vitamin K depletion in hospitalized patients. |
PubMed:Abbreviated hospitalization for deep venous thrombosis with the use of ardeparin. |
PubMed:Clinical pharmacokinetics of nimesulide. |
PubMed:Rational assessment of the interaction profile of cerivastatin supports its low propensity for drug interactions. |
PubMed:The antiplatelet effects of ticlopidine and clopidogrel. |
PubMed:Grapefruit juice and the response to warfarin. |
PubMed:Modern management of prosthetic valve anticoagulation. |
PubMed:Azimilide dihydrochloride, a novel antiarrhythmic agent. |
PubMed:Pharmacokinetics of grepafloxacin. |
PubMed:Clinical pharmacokinetics of nefazodone. |
PubMed:Probable interaction between warfarin and ginseng. |
PubMed:Dietary vitamin K1 and stability of oral anticoagulation: proposal of a diet with constant vitamin K1 content. |
PubMed:The clinical pharmacokinetics of levofloxacin. |
PubMed:Interventional cardiology and intracoronary stents--a changing practice: approved vs. nonapproved indications. |
PubMed:Comparison of two methods for INR determination in a pharmacist-based oral anticoagulation clinic. |
PubMed:Warfarin resistance: diagnosis and therapeutic alternatives. |
PubMed:Vitamin K status influences brain sulfatide metabolism in young mice and rats. |
PubMed:Hail stentors! How the hail do I stop the warfarin? |
PubMed:Olestra and the FDA. |
PubMed:When discharging patients on coumadin, heed this advice. |
PubMed:A review of the clinical pharmacokinetics of meloxicam. |
PubMed:HPLC determination of anticoagulant rodenticide residues in animal livers. |
PubMed:Development and pharmacology of fluvastatin. |
PubMed:Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. |
PubMed:[Warfarin therapy and chlorella]. |
PubMed:Clinical pharmacokinetics of lansoprazole. |
PubMed:Pharmacokinetic development of quinolone antibiotics. |
PubMed:Drug-food interactions in clinical practice. |
PubMed:Protease inhibitors: where are they now? |
PubMed:Overview of the pharmacokinetics of fluvoxamine. |
PubMed:Development and pharmacology of fluvastatin. |
PubMed:Interactions of warfarin with drugs and food. |
PubMed:Clinical pharmacokinetics of pravastatin. |
PubMed:Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents. |
PubMed:Outpatient use of a portable international normalized ratio/prothrombin time monitor. |
PubMed:An outbreak of vampire bat bite in a Brazilian village. |
PubMed:Accidental poisoning by warfarin-contaminated herbal tea. |
PubMed:Benazepril: a new ACE inhibitor. |
PubMed:Low molecular weight heparins. An objective overview. |
PubMed:Factors that influence therapeutic anticoagulation control. |
PubMed:Development of a diet low in vitamin K-1 (phylloquinone). |
PubMed:The Carpentier-Edwards pericardial aortic valve: intermediate results. |
PubMed:Vancomycin, metronidazole, and tetracyclines. |
PubMed:Interactions of fluoroquinolones with other drugs: mechanisms, variability, clinical significance, and management. |
PubMed:Clinical toleration and safety of azithromycin. |
PubMed:[Oral anticoagulant therapy with special reference to the influence of food and drug interactions]. |
PubMed:Adverse reaction reporting of interaction between warfarin and fluoroquinolones. |
PubMed:Some properties of rat platelet aggregation and effects of butylated hydroxytoluene, warfarin and aspirin. |
PubMed:Anticoagulation instability with life-threatening complication after dietary modification. |
PubMed:Reversal of osmolite-warfarin interaction by changing warfarin administration time. |
PubMed:Warfarin antagonism of natto and increase in serum vitamin K by intake of natto. |
PubMed:Recovery of warfarin from an enteral nutrient formula. |
PubMed:Unsuspected source of vitamin K in patients treated with anticoagulants: a case report. |
PubMed:Pharmacokinetic characteristics of roxatidine. |
PubMed:Propafenone: a new antiarrhythmic agent. |
PubMed:Biology, ecology, and control of the vampire bat. |
PubMed:An attempted homicide using d-CON rat poison. |
PubMed:Clinical pharmacokinetics of ketoconazole. |
PubMed:Liquid chromatographic determination of coumarin anticoagulants in tablets: collaborative study. |
PubMed:Is the dose of warfarin prescribed by American physicians unnecessarily high? |
PubMed:Drug interactions in surgical patients. |
PubMed:Maternal toxicity in humans and animals: effects on fetal development and criteria for detection. |
PubMed:Drug-food interaction information: a file card for patient education. |
PubMed:Warfarin and enteral nutrition products. |
PubMed:Metabolism and disposition of buspirone. |
PubMed:The metabolic disposition of acifran, a new antihyperlipidemic agent, in rats and dogs. |
PubMed:[Resistance to vitamin K antagonists. 6 cases]. |
PubMed:On the influence of vitamin K-rich vegetables and wine on the effectiveness of warfarin treatment. |
PubMed:[Diagnostic aspects and results of drug therapy in pulmonary thromboembolism]. |
PubMed:[Thrombolytic therapy with urokinase in 8 patients with massive pulmonary thromboembolism]. |
PubMed:Warfarin resistance linked to enteral nutrition products. |
PubMed:Enalapril: a review of human pharmacology. |
PubMed:Interactions of analgesics with other drugs. |
PubMed:Laboratory tests of seven rodenticides for the control of Meriones shawi. |
PubMed:A comparative assessment of efficacy of three anticoagulant rodenticides. |
PubMed:Liquid nutrition as a cause of warfarin resistance. |
PubMed:Clinical Pharmacokinetics of indomethacin. |
PubMed:Acquired warfarin resistance and weight-reducing diet. |
PubMed:Warfarin resistance and vitamin K. |
PubMed:Institutional pharmacists' guide to complying with PPI regulations. |
PubMed:Warfarin dosage and vitamin K in Osmolite. |
PubMed:"Resistance" to warfarin due to unrecognized vitamin K supplementation. |
PubMed:Problems encountered in protecting stored grain from damage by rodents, birds, insects and mites in England and Wales. |
PubMed:Inhibition of the hypoprothrombinemic effect of warfarin (Coumadin) by Ensure Plus, a dietary supplement. |
PubMed:The influence of fasting on the disposition of warfarin in rats. |
PubMed:Trials of the anticoagulants rodenticide WBA 8119 against confined colonies of warfarin-resistant house mice (Mus musculus L.). |
PubMed:Trials of the anticoagulant rodenticide WBA 8119 against confined colonies of warfarin-resistant house mice (Mus musculus L.). |
PubMed:Laboratory evaluation of WBA 8119 as a rodenticide for use against warfarin-resistant and non-resistant rats and mice. |
PubMed:Some properties of calciferol as a rodenticide. |
PubMed:MR-100: an anticoagulant rodenticide. |
PubMed:Japanese-restaurant syndrome. |
PubMed:Effect of silicones on the absorption of anticoagulant drugs. |
PubMed:New rodenticide, 'MR-100', containing a taste enhancer. |